As for serum complement C5, Hu et al. [85] revealed that serum C5 levels were associated with NAFLD and Hillebrandt et al. [86] found that C5 is a causal effector of liver fibrosis. Here, C5 is linked to metabolic dysfunction-associated steatotic liver disease.